PTGER4 and urinary bladder cancer: However, onco-suppressor activities of the miR-17-92a cluster have also been reported, including anti-proliferative and senescence effects in bladder cancer cells38 and in prostate39 and gastric40 cancers by targeting, among other pathways, the NOTCH/EP4 pathway.